These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1226 related items for PubMed ID: 17286630

  • 1. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
    Vadoud-Seyedi J, Simonart T.
    Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
    [Abstract] [Full Text] [Related]

  • 2. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study.
    Güleç AT.
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):314-8. PubMed ID: 21492253
    [Abstract] [Full Text] [Related]

  • 3. Low-dose efficacy of botulinum toxin A for axillary hyperhidrosis: a randomized, side-by-side, open-label study.
    Heckmann M, Plewig G, Hyperhidrosis Study Group.
    Arch Dermatol; 2005 Oct; 141(10):1255-9. PubMed ID: 16230563
    [Abstract] [Full Text] [Related]

  • 4. Botulinum toxin A for axillary hyperhidrosis (excessive sweating).
    Heckmann M, Ceballos-Baumann AO, Plewig G, Hyperhidrosis Study Group.
    N Engl J Med; 2001 Feb 15; 344(7):488-93. PubMed ID: 11172190
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of botulinum toxin type A in the treatment of focal axillary hyperhidrosis.
    Absar MS, Onwudike M.
    Dermatol Surg; 2008 Jun 15; 34(6):751-5. PubMed ID: 18318723
    [Abstract] [Full Text] [Related]

  • 6. A double-blind, randomized, comparative study of two type A botulinum toxins in the treatment of primary axillary hyperhidrosis.
    Talarico-Filho S, Mendonça DO Nascimento M, Sperandeo DE Macedo F, DE Sanctis Pecora C.
    Dermatol Surg; 2007 Jan 15; 33(1 Spec No.):S44-50. PubMed ID: 17241414
    [Abstract] [Full Text] [Related]

  • 7. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
    Naumann M, Lowe NJ, Kumar CR, Hamm H, Hyperhidrosis Clinical Investigators Group.
    Arch Dermatol; 2003 Jun 15; 139(6):731-6. PubMed ID: 12810503
    [Abstract] [Full Text] [Related]

  • 8. [Efficacy of botulinum toxin A in the treatment of axillary and palmar hyperhidrosis: 10 cases].
    Maillard H, Briand N, Bara C, Celerier P.
    Ann Dermatol Venereol; 2003 May 15; 130(5):511-3. PubMed ID: 12843826
    [Abstract] [Full Text] [Related]

  • 9. Axillary injection of botulinum A toxin in a patient with muscle cramps associated with severe axillary hyperhidrosis.
    Filosto M, Bertolasi L, Fincati E, Priori A, Tomelleri G, Chieregato G, Rizzuto N.
    Acta Neurol Belg; 2001 Jun 15; 101(2):121-3. PubMed ID: 11486559
    [Abstract] [Full Text] [Related]

  • 10. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety.
    Lowe NJ, Glaser DA, Eadie N, Daggett S, Kowalski JW, Lai PY, North American Botox in Primary Axillary Hyperhidrosis Clinical Study Group.
    J Am Acad Dermatol; 2007 Apr 15; 56(4):604-11. PubMed ID: 17306417
    [Abstract] [Full Text] [Related]

  • 11. Skin cooling for botulinum toxin A injection in patients with focal axillary hyperhidrosis: a prospective, randomized, controlled study.
    Bechara FG, Sand M, Altmeyer P, Sand D, Hoffmann K.
    Ann Plast Surg; 2007 Mar 15; 58(3):299-302. PubMed ID: 17471136
    [Abstract] [Full Text] [Related]

  • 12. Durability of botulinum toxin treatment for axillary hyperhidrosis.
    Moffat CE, Hayes WG, Nyamekye IK.
    Eur J Vasc Endovasc Surg; 2009 Aug 15; 38(2):188-91. PubMed ID: 19395290
    [Abstract] [Full Text] [Related]

  • 13. Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms.
    Schnider P, Binder M, Auff E, Kittler H, Berger T, Wolff K.
    Br J Dermatol; 1997 Apr 15; 136(4):548-52. PubMed ID: 9155956
    [Abstract] [Full Text] [Related]

  • 14. Lidocaine tape (Penles) reduces the pain of botulinum toxin injection for Meige syndrome.
    Onguchi T, Takano Y, Dogru M, Ono M, Tsubota K.
    Am J Ophthalmol; 2004 Oct 15; 138(4):654-5. PubMed ID: 15488799
    [Abstract] [Full Text] [Related]

  • 15. Bupivacaine-induced myotoxicity and its effect on botulinum toxin paresis.
    Yen MT, Wall VK.
    Ann Plast Surg; 2008 Jan 15; 60(1):6-9. PubMed ID: 18281786
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The combined use of forced cold air and topical anesthetic cream for analgesia during the treatment of palmar hyperhydrosis with botulinum toxin injections.
    Patel R, Halem M, Zaiac M.
    J Drugs Dermatol; 2009 Oct 15; 8(10):948-51. PubMed ID: 19852126
    [Abstract] [Full Text] [Related]

  • 19. Intravenous regional anesthesia (Bier's block) for botulinum toxin therapy of palmar hyperhidrosis is safe and effective.
    Blaheta HJ, Vollert B, Zuder D, Rassner G.
    Dermatol Surg; 2002 Aug 15; 28(8):666-71; discussion 671-2. PubMed ID: 12174055
    [Abstract] [Full Text] [Related]

  • 20. Topically applied botulinum toxin type A for the treatment of primary axillary hyperhidrosis: results of a randomized, blinded, vehicle-controlled study.
    Glogau RG.
    Dermatol Surg; 2007 Jan 15; 33(1 Spec No.):S76-80. PubMed ID: 17241418
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 62.